A TRF1-controlled common fragile site containing interstitial telomeric sequences

Chromosoma

Volumn 121, Issue 5, 2012, Pages 465-474

  Bosco, Nazario ^a   De Lange, Titia ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATR PROTEIN; BLOOM SYNDROME HELICASE; TELOMERIC REPEAT BINDING FACTOR 1;

ARTICLE; BINDING AFFINITY; CHROMOSOME 2Q; CHROMOSOME ANALYSIS; CHROMOSOME STRUCTURE; COMMON FRAGILE SITE; CONTROLLED STUDY; DNA SEQUENCE; PROTEIN FUNCTION; SEQUENCE ANALYSIS; TELOMERE;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CHROMOSOMAL INSTABILITY; CHROMOSOME FRAGILE SITES; CHROMOSOMES, HUMAN, PAIR 2; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 1;

EID: 84867642761     PISSN: 00095915     EISSN: 14320886     Source Type: Journal    
DOI: 10.1007/s00412-012-0377-6     Document Type: Article

References (62)

1. Alvarez L, Evans JW, Wilks R, Lucas JN, Brown JM, Giaccia AJ (1993) Chromosomal radiosensitivity at intrachromosomal telomeric sites. Genes Chromosomes Cancer 8:8-14
2. Ashley T, Ward DC (1993) A "hot spot" of recombination coincides with an interstitial telomeric sequence in the Armenian hamster. Cytogenet Cell Genet 62:169-171
3. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Orntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG (2006) Oncogeneinduced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633-637
4. Bertoni L, Attolini C, Tessera L, Mucciolo E, Giulotto E (1994) Telomeric and nontelomeric (TTAGGG)n sequences in gene amplification and chromosome stability. Genomics 24:53-62
5. Bester AC, Schwartz M, Schmidt M, Garrigue A, Hacein-Bey-Abina S, Cavazzana-Calvo M, Ben-Porat N, Von Kalle C, Fischer A, Kerem B (2006) Fragile sites are preferential targets for integrations of MLV vectors in gene therapy. Gene Ther 13:1057-1059
6. Bester AC, Roniger M, Oren YS, ImMM, Sarni D, ChaoatM, Bensimon A, Zamir G, Shewach DS, Kerem B (2011) Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145:435-446
7. Bianchi A, Smith S, Chong L, Elias P, de Lange T (1997) TRF1 is a dimer and bends telomeric DNA. Embo J 16:1785-1794
8. Bianchi A, Stansel RM, Fairall L, Griffith JD, Rhodes D, de Lange T (1999) TRF1 binds a bipartite telomeric site with extreme spatial flexibility. Embo J 18:5735-5744
9. BignellGR, Greenman CD, Davies H, Butler AP, Edkins S,Andrews JM, Buck G, Chen L, Beare D, Latimer C, Widaa S, Hinton J, Fahey C, Fu B, Swamy S, Dalgliesh GL, Teh BT, Deloukas P, Yang F, Campbell PJ, Futreal PA, Stratton MR (2010) Signatures of mutation and selection in the cancer genome. Nature 463:893-898
10. Brueckner LM, Sagulenko E, Hess EM, Zheglo D, Blumrich A, Schwab M, Savelyeva L (2012) Genomic rearrangements at the FRA2H common fragile site frequently involve non-homologous recombination events across LTR and L1(LINE) repeats. Hum Genet. doi:10.1007/s00439-012-1165-3
11. Chu WK, Hickson ID (2009) RecQ helicases: multifunctional genome caretakers. Nat Rev Cancer 9:644-654
12. Ciullo M, Debily MA, Rozier L, Autiero M, Billault A, Mayau V, El Marhomy S, Guardiola J, Bernheim A, Coullin P, Piatier-Tonneau D, Debatisse M (2002) Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. Hum Mol Genet 11:2887-2894
13. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M (1997) Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89:215-225
14. Cortez D, Guntuku S, Qin J, Elledge SJ (2001) ATR and ATRIP: partners in checkpoint signaling. Science 294:1713-1716
15. Day JP, Limoli CL, Morgan WF (1998) Recombination involving interstitial telomere repeat-like sequences promotes chromosomal instability in Chinese hamster cells. Carcinogenesis 19:259-65
16. de Lange T (2009) How telomeres solve the end-protection problem. Science 326:948-952
17. Dereli-Oz A, Versini G, Halazonetis TD (2011) Studies of genomic copy number changes in human cancers reveal signatures of DNA replication stress. Mol Oncol 5:308-314
18. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre M, Nuciforo PG, Bensimon A, Maestro R, Pelicci PG, d'Adda di Fagagna F (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyperreplication. Nature 444:638-642
19. Durkin SG, Glover TW (2007) Chromosome fragile sites. Annu Rev Genet 41:169-192
20. Feichtinger W, Schmid M (1989) Increased frequencies of sister chromatid exchanges at common fragile sites (1)(q42) and (19)(q13). Hum Genet 83:145-147
21. Fernandez JL, Gosalvez J, Goyanes V (1995) High frequency of mutagen-induced chromatid exchanges at interstitial telomerelike DNA sequence blocks of Chinese hamster cells. Chromosome Res 3:281-284
22. Fundia A, Gorla N, Larripa I (1995) Non-random distribution of spontaneous chromosome aberrations in two Bloom syndrome patients. Hereditas 122:239-243
23. Glover TW, Stein CK (1987) Induction of sister chromatid exchanges at common fragile sites. Am J Hum Genet 41:882-890
24. Glover TW, Stein CK (1988) Chromosome breakage and recombination at fragile sites. Am J Hum Genet 43:265-273
25. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RAJ, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434:907-913
26. Hastie ND, Allshire RC (1989) Human telomeres: fusion and interstitial sites. Trends Genet 5:326-331
27. Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, Smith DI, Trakhtenbrot L, Kerem B (2002) A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 1:89-97
28. Helmrich A, Ballarino M, Tora L (2011) Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol Cell 44:966-977
29. Ijdo JW, Baldini A, Ward DC, Reeders ST, Wells RA (1991) Origin of human chromosome 2: an ancestral telomere-telomere fusion. Proc Natl Acad Sci U S A 88:9051-9055
30. Kilburn AE, Shea MJ, Sargent RG, Wilson JH (2001) Insertion of a telomere repeat sequence into a mammalian gene causes chromosome instability. Mol Cell Biol 21:126-35
31. Krutilina RI, Oei S, Buchlow G, Yau PM, Zalensky AO, Zalenskaya IA, Bradbury EM, Tomilin NV (2001) A negative regulator of telomere-length protein trf1 is associated with interstitial (TTAGGG)n blocks in immortal Chinese hamster ovary cells. Biochem Biophys Res Commun 280:471-45
32. Le Tallec B, Dutrillaux B, Lachages AM, Millot GA, Brison O, Debatisse M (2011) Molecular profiling of common fragile sites in human fibroblasts. Nat Struct Mol Biol 18:1421-1423
33. Letessier A, Millot GA, Koundrioukoff S, Lachages AM, Vogt N, Hansen RS, Malfoy B, Brison O, Debatisse M (2011) Cell-typespecific replication initiation programs set fragility of the FRA3B fragile site. Nature 470:120-123
34. Loayza D, de Lange T (2003) POT1 as a terminal transducer of TRF1 telomere length control. Nature 424:1013-1018
35. Martinez P, Thanasoula M, Munoz P, Liao C, Tejera A, McNees C, Flores JM, Fernandez-Capetillo O, Tarsounas M, Blasco MA (2009) Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev 23:2060-2075
36. Matzner I, Savelyeva L, Schwab M (2003) Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of a breast cancer cell line. Cancer Lett 189:207-219
37. Miller CT, Lin L, Casper AM, Lim J, Thomas DG, Orringer MB, Chang AC, Chambers AF, Giordano TJ, Glover TW, Beer DG (2006) Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 25:409-418
38. Mishmar D, Rahat A, Scherer SW, Nyakatura G, Hinzmann B, Kohwi Y, Mandel-Gutfroind Y, Lee JR, Drescher B, Sas DE, Margalit H, Platzer M, Weiss A, Tsui LC, Rosenthal A, Kerem B (1998) Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci U S A 95:8141-8146
39. Mrasek K, Schoder C, Teichmann AC, Behr K, Franze B, Wilhelm K, Blaurock N, Claussen U, Liehr T, Weise A (2010) Global screening and extended nomenclature for 230 aphidicolin-inducible fragile sites, including 61 yet unreported ones. Int J Oncol 36:929-940
40. Ozeri-Galai E, Lebofsky R, Rahat A, Bester AC, Bensimon A, Kerem B (2011) Failure of origin activation in response to fork stalling leads to chromosomal instability at fragile sites. Mol Cell 43:122-131
41. Palm W, de Lange T (2008) How shelterin protects mammalian telomeres. Annu Rev Genet 42:301-334
42. Pelliccia F, Bosco N, Curatolo A, Rocchi A (2008) Replication timing of two human common fragile sites: FRA1H and FRA2G. Cytogenet Genome Res 121:196-200
43. Pelliccia F, Bosco N, Rocchi A (2010) Breakages at common fragile sites set boundaries of amplified regions in two leukemia cell lines K562-molecular characterization of FRA2H and localization of a new CFS FRA2S. Cancer Lett 299:37-44
44. Ragland RL, Glynn MW, Arlt MF, Glover TW (2008) Stably transfected common fragile site sequences exhibit instability at ectopic sites. Genes Chromosomes Cancer 47:860-872
45. Rassool FV, McKeithan TW, Neilly ME, van Melle E, Rr E, Le Beau MM (1991) Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites. Proc Natl Acad Sci U S A 88:6657-6661
46. Reshmi SC, Huang X, Schoppy DW, Black RC, Saunders WS, Smith DI, Gollin SM (2007) Relationship between FRA11F and 11q13 gene amplification in oral cancer. Genes Chromosomes Cancer 46:143-154
47. Salvati E, Scarsella M, PorruM, Rizzo A, Iachettini S, Tentori L, Graziani G, D'Incalci M, Stevens MF, Orlandi A, Passeri D, Gilson E, Zupi G, Leonetti C, Biroccio A (2010) PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy. Oncogene 29:6280-6293
48. Schwartz M, Zlotorynski E, Kerem B (2006) The molecular basis of common and rare fragile sites. Cancer Lett 232:13-26
49. Sfeir A, Kosiyatrakul ST, Hockemeyer D, MacRae SL, Karlseder J, Schildkraut CL, de Lange T (2009) Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138:90-103
50. Simonet T, Zaragosi LE, Philippe C, Lebrigand K, Schouteden C, Augereau A, Bauwens S, Ye J, Santagostino M, Giulotto E, Magdinier F, Horard B, Barbry P, Waldmann R, Gilson E (2011) The human TTAGGG repeat factors 1 and 2 bind to a subset of interstitial telomeric sequences and satellite repeats. Cell Res 21:1028-1038
51. Slijepcevic P, Xiao Y, Dominguez I, Natarajan AT (1996) Spontaneous and radiation-induced chromosomal breakage at interstitial telomeric sites. Chromosoma 104:596-604
52. Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G, de Lange T (2000) Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20:1659-1668
53. Sutherland GR, Mattei JF (1987) Report of the committee on cytogenetic markers. Cytogenet Cell Genet 46:316-324
54. Sutherland GR, Baker E, Richards RI (1998) Fragile sites still breaking. Trends Genet 14:501-506
55. Takai KK, Hooper S, Blackwood S, Gandhi R, de Lange T (2010) In vivo stoichiometry of shelterin components. J Biol Chem 285:1457-1467
56. Thorland EC, Myers SL, Gostout BS, Smith DI (2003) Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 22:1225-1237
57. Tsantoulis PK, Kotsinas A, Sfikakis PP, Evangelou K, Sideridou M, Levy B, Mo L, Kittas C, Wu XR, Papavassiliou AG, Gorgoulis VG (2008) Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genomewide study. Oncogene 27:3256-3264
58. Vannier JB, Pavicic-Kaltenbrunner V, Petalcorin MI, Ding H, Boulton SJ (2012) RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell 149:795-806
59. Wilke CM, Hall BK, Hoge A, ParadeeW, Smith DI, Glover TW (1996) FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 5:187-195
60. Yang D, Xiong Y, Kim H, He Q, Li Y, Chen R, Songyang Z (2011) Human telomeric proteins occupy selective interstitial sites. Cell Res 21:1013-1027
61. Zimonjic DB, Durkin ME, Keck-Waggoner CL, Park SW, Thorgeirsson SS, Popescu NC (2003) SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma. Neoplasia 5:390-396
62. Zlotorynski E, Rahat A, Skaug J, Ben-Porat N, Ozeri E, Hershberg R, Levi A, Scherer SW, Margalit H, Kerem B (2003) Molecular basis for expression of common and rare fragile sites. Mol Cell Biol 23:7143-7151